Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SPHDF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$262.62M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Santhera Pharmaceuticals Holding AGSanthera Pharmaceuticals Holding AG-6.4-1579%1.8-7.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$262.62 Million
Enterprise Value$268.37 Million
Earnings per Share$-3.78
Beta-0.28
Outstanding Shares14,351,000

Return

Return on Equity1579.02%ROE
Return on Assets-66.20%
Return on Invested Capital-47.82%

Valuation & Multiples

P/E Ratio-6.41P/E Ratio
PEG14.39PEG
Price to Sales1.83Price to Sales
Price to Book Ratio-18.3Price to Book Ratio
Enterprise Value to Revenue1.78
Enterprise Value to EBIT-5.67
Enterprise Value to Net Income-3
Total Debt to Enterprise0.18
Debt to Equity-7.7Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 30, 2026
EPS
-$1.86
Reported
Revenue
$59.79 M
Est. $58.14 M

Next Earnings Call

Expected Date
April 29, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
$43.74 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Santhera Pharmaceuticals Holding AG

78 employees
CEO: Orlando Oliveira

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America...